International NIPT Workshop – Clinical Considerations and Future Directions.
March 7th 8:30 AM
8:30 Breakfast hosted by Illumina
9:00 General Introductions – Pavel Calda, MD PhD, Professor, Head of the Centre of Fetal Medicine and Ultrasound Unit Charles University in Prague
9:15 NIPT History/Background – Pavel Calda, MD PhD
10:00 Technological Comparison / Current Testing Overview – Christin Coffeen, Illumina Genetic Counselor
10:30 Coffee Break
10:45 NIPT in average risk population – Gyula Richárd Nagy MD, PhD, Director, Intelligenetic ltd
11:15 Evolution of NIPT, what’s next (test menu and logistics) – Nargol Faraveshi, Sr. Manager for Product Development for NIPT at Illumina
11:45 – 1pm
Panel Discussion with Q&A – open discussion for the audience to ask questions of the Advisory Session Members
Moderator: Dr. Sucheta Bhatt, Director, Genetics, Illumina
- Clinical implementations considerations: physician perspective
- NIPT in high risk women
- NIPT in average risk women: how should NIPT be used in general OB-GYN population?
- NIPT for microdeletions: how to integrate into clinical practice?
- Lab preference: local or acceptable to work with labs overseas? VeriSeqNIPT Solution
- Implications of failed NIPT results and TAT
- Clinical implementations considerations : regional healthcare perspective
- Regional patient education
- Future directions of cell-free nucleic acid technology
1:00 Lunch
Translation service will be provided
Workshop languages are English and Czech, presentations will be translated sibultaneously to both languages
sponsored by Illumina
